SCHEMBL30256774

SCHEMBL30256774

CC(O)(CO)[C@@H]1Cc2c(ccc3ccc(=O)oc23)O1

nearest known ligand 0.79

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 10/20 0.79
▸ HPGD P15428 9/20 0.79
▸ ALDH1A1 P00352 8/20 0.79
▸ GAA P10253 2/20 0.79
▸ ABCB1 P08183 1/20 0.61
▸ LMNA P02545 3/20 0.59
▸ HSD17B10 Q99714 3/20 0.50
▸ CYP3A4 P08684 3/20 0.50
▸ MAPT P10636 1/20 0.50
▸ ACHE P22303 1/20 0.45
▸ NPC1 O15118 1/20 0.45
▸ DPP4 P27487 2/20 0.43
▸ CYP1A2 P05177 2/20 0.40
▸ TSHR P16473 1/20 0.40
▸ THPO P40225 1/20 0.40
▸ STAT6 P42226 1/20 0.40
▸ BLM P54132 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Columbianetin SCHEMBL20356593 0.88 KDM4E (1.00) KDM4EHPGDALDH1A1GAAABCB1
Columbianetin SCHEMBL50251 0.88 KDM4E (1.00) KDM4EHPGDALDH1A1GAAABCB1
Columbianetin SCHEMBL21527679 0.88 KDM4E (1.00) KDM4EHPGDALDH1A1GAAABCB1
SCHEMBL12247775 0.80 KDM4E (0.79) KDM4EHPGDALDH1A1GAAABCB1
SCHEMBL29390971 0.76 ABCB1 (1.00) KDM4EHPGDALDH1A1GAAABCB1
SCHEMBL30794498 0.75 KDM4E (0.74) KDM4EHPGDALDH1A1GAAABCB1
Columbianadin SCHEMBL14424509 0.75 KDM4E (1.00) KDM4EHPGDALDH1A1GAAABCB1
SCHEMBL14444001 0.71 ATP1A1 (0.48) KDM4EHPGDALDH1A1GAA
Angelmarin SCHEMBL30443353 0.70 KDM4E (0.63) KDM4EHPGDALDH1A1GAAABCB1
Angelmarin SCHEMBL29507688 0.70 KDM4E (0.63) KDM4EHPGDALDH1A1GAAABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230041289-A1 COMPOSITIONS AND METHODS FOR ENHANCING OR TREATING FEMALE SEXUAL RESPONSE T K INC APS (DK) 2023-02-09 — — US disclosed
Send feedback